Inizio Biotech Appoints Jay Janus as Senior Account Manager
In his role, Janus will act as the main point of contact for emerging biotech partners, providing them with strategic advice and connecting them to the knowledge and expertise of the expanded Inizio network at the right times in their development journey.
He has extensive experience advising early stage companies in the area of clinical trials with extensive experience in medical writing, biostatistics, clinical trial design and data management.
Commenting on his appointment, Janus said: “Emerging biotech companies have become incredibly skilled at developing molecules and advancing trials, but their journey to market requires additional expertise and guidance to realize the potential and value of each. business and their assets.
“It is this gap that Inizio Biotech fills by acting as a strategic thinking partner with access to specialized resources across the commercialization spectrum. Our customers can access as little or as much access as they need, when they need it, and that’s what really sets us apart. I am delighted to join the company at a time when the industry continues to go from strength to strength.
Inizio Biotech provides personalized solutions, coordinated by unique strategic points of contact supported by more than 10,000 experts. This includes more than 650 doctors providing therapeutic area and modality expertise throughout the clinical development and commercialization journey.
Commenting on the appointment, Inizio Biotech’s Global President Jason McKenna said, “Jay joins us at a key time in Inizio Biotech’s journey. Emerging biotechs are increasingly turning to us not only to consult, but also to quickly build a highly personalized, multi-disciplinary team that can maximize the real value of their asset. I look forward to the future success of our clients with Jay’s guidance by their side. »